INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5
October 22 2018 - 5:00PM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the
development, manufacture and commercialization of pharmaceutical
cannabinoids and spray technology, today announced that it will
release its third quarter 2018 financial results on Monday, Nov. 5,
after the U.S. financial markets close.
Following the release, Saeed Motahari, president
and chief executive officer, and Andy Long, chief financial
officer, will host a conference call at 5:00 p.m. Eastern Time to
discuss the results.
Interested parties can listen to the call live
as it occurs via the company’s website, https://www.insysrx.com/,
on the Investors section’s Presentations & Events page; or by
dialing 844-263-8304 (from inside the U.S.) or 213-358-0958 (from
outside the U.S.) and using the Conference ID 6149699. A webcasted
replay of the call will be available on the site a few hours after
the event.
About INSYS
INSYS Therapeutics is a specialty pharmaceutical company that
develops and commercializes innovative drugs and novel drug
delivery systems of therapeutic molecules that improve patients’
quality of life. Using proprietary spray technology and
capabilities to develop pharmaceutical cannabinoids, INSYS is
developing a pipeline of products intended to address unmet medical
needs and the clinical shortcomings of existing commercial
products. The company is committed to developing medications for
potentially treating anaphylaxis, epilepsy, Prader-Willi syndrome,
opioid addiction and overdose, and other disease areas with a
significant unmet need.
CONTACT: |
Corporate Communications |
Investor Relations |
|
|
|
Joe McGrath |
Jackie Marcus or Chris Hodges |
|
|
|
INSYS Therapeutics |
Alpha IR Group |
|
|
|
480-500-3101 |
312-445-2870 |
|
|
|
jmcgrath@insysrx.com |
INSY@alpha-ir.com |
|
|
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Aug 2024 to Sep 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Sep 2023 to Sep 2024